ATAI

ATAI Life Sciences N.V.

1.58 USD
+0.01 (+0.64%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ATAI Life Sciences N.V. stock is up 12.86% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 July’s closed higher than June.

About ATAI Life Sciences N.V.

Atai Life Sciences N.V. operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD)